NEW YORK (Reuters Health) – Taking levothyroxine on an empty stomach at bedtime, instead of in the morning before breakfast, significantly improves thyroid hormone levels and many patients…
NEW YORK (Reuters Health) – A new test makes feasible the early detection of Turner syndrome, according to a report in the December 8 issue of The Journal…
NEW YORK (Reuters Health) – A study of Chernobyl survivors shows no difference in recurrence patterns between radiation-related and sporadic thyroid cancers. “Similar treatment approaches should be recommended…
NEW YORK (Reuters Health) – For women of normal weight or moderate overweight who develop gestational diabetes late in pregnancy, treatment with metformin may be a suitable alternative…
NEW YORK (Reuters Health) – The management of heart failure guided by an individualized target level of N-terminal pro-B-type natriuretic peptide (NT-proBNP) doesn’t lead to clinically significant improvements…
NEW YORK (Reuters Health) – The mineralocorticoid receptor blocker eplerenone has advantages over spironolactone in the treatment of chronic heart failure (CHF), a Japanese team reports. In particular,…
NEW YORK (Reuters Health) – Elevated systolic blood pressure and low diastolic blood pressure are associated with increased risk of cardiovascular disease (CVD) among patients with type 2…
NEW YORK (Reuters Health) – Short-term testosterone treatment in frail elderly men improves muscle mass and strength, but the effects don’t last more than 6 months after treatment…
NEW YORK (Reuters Health) – A population-based study from Scotland shows that fewer than one in every 100 patients with subclinical hyperthyroidism will progress to overt hyperthyroidism. In…